You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Title |
Frontline treatment of epithelial ovarian cancer
|
---|---|
Published in |
Asia Pacific Journal of Clinical Oncology, December 2015
|
DOI | 10.1111/ajco.12449 |
Pubmed ID | |
Authors |
Jeffrey Goh, G Raj Mohan, Rahul Ladwa, Sumitra Ananda, Paul A Cohen, Sally Baron-Hay |
Abstract |
This is a contemporaneous review of the frontline treatment of epithelial ovarian cancer (EOC), specifically on the importance of optimal surgical cytoreductive surgery, the pivotal role of platinum-based adjuvant chemotherapy (which encompasses intraperitoneal and dose-dense regimens) and the emergence of neo-adjuvant chemotherapy. Additionally, the benefit of concurrent and maintenance bevacizumab in the suboptimally debullked stage III and stage IV EOC setting is also reviewed. The article also discusses the increasing importance of prognostic and predictive molecular biomarkers in the future management of EOC. |
Mendeley readers
The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 54 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 7 | 13% |
Student > Master | 6 | 11% |
Student > Doctoral Student | 6 | 11% |
Student > Bachelor | 5 | 9% |
Other | 5 | 9% |
Other | 15 | 28% |
Unknown | 10 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 30 | 56% |
Agricultural and Biological Sciences | 2 | 4% |
Biochemistry, Genetics and Molecular Biology | 2 | 4% |
Immunology and Microbiology | 2 | 4% |
Business, Management and Accounting | 1 | 2% |
Other | 3 | 6% |
Unknown | 14 | 26% |